Identifying Market Opportunities Daily

Each morning before the market opens, we deliver a timely trade idea to our subscribers.

Recent Ideas

FedEx (FDX)

FedEx (FDX) just refilled its bearish gap around $202 and could see higher highs. Helping, Bank of America and Citi analysts just upgraded the stock to a buy. Citi now has a price target of $240 thanks to better price controls. “We previously noted the F2H weighting...

Altria Group (MO)

Keep an eye on Altria Group (MO). Not only does it carry a respectable yield of 8.35%, the company also just announced a $1 billion stock buyback program. The company also posted solid earnings, with EPS of $1.18 beating expectations for $1.17. And while sales did...

Lithium Americas (LAC)

Just yesterday, we noted, “One of the top lithium stocks to consider on that news is Lithium Americas (LAC). Not only is lithium demand fueling upside in the stock, so is news it’s preparing construction, and potential supply agreements and partnerships for Thacker...

Lithium Americas (LAC)

Lithium stocks could be some of the hottest stocks of 2023. For one, demand is accelerating. In fact, according to USA Today, electric vehicles made up about 5% of new auto sales in 2022. Analysts at S&P Global Mobility see that number rising to about 8% of the...

Tesla (TSLA)

Tesla (TSLA) is showing big signs of life again. After getting hammered on Chinese lockdowns, Twitter, a potential recession, slowing sales, you name it, Tesla is accelerating again. For one, the electric vehicle boom has only just begun. Two, Tesla just reported EPS...

Johnson & Johnson (JNJ)

Investors may want to pay close attention to Johnson & Johnson (JNJ). After a rough start for the year, the JNJ stock appears to have caught strong double bottom support. It has also become excessively oversold on RSI, MACD, and Williams’ %R. Better, JNJ carries a...

Pfizer (PFE)

Recent weakness in Pfizer (PFE) looks interesting. In fact, after dropping from about $55 to $44.71, it’s now wildly oversold on RSI, MACD, and Williams’ %R. From here, we believe PFE could test $48 resistance again shortly. Helping, the US FDA is considering an...

Sponsored Content